Current therapies for hypertrophic cardiomyopathy: a systematic review and meta‐analysis of the literature-Reference-Cited by-同舟云学术

Current therapies for hypertrophic cardiomyopathy: a systematic review and meta‐analysis of the literature

Published:2022-10 Issue:1 Volume:10 Page:8-23
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Bayonas‐Ruiz Adrián¹,Muñoz‐Franco Francisca María²,Sabater‐Molina María³⁴,Oliva‐Sandoval María José²⁴,Gimeno Juan R.²⁴⁵^ORCID,Bonacasa Bárbara¹^ORCID

Affiliation:

1. Research Group of Physical Exercise and Human Performance, Faculty of Sport Sciences University of Murcia Murcia Spain

2. Inherited Cardiac Disease Unit (CSUR) Hospital Universitario Virgen de la Arrixaca Murcia Spain

3. Cardiogenetic Laboratory Instituto Murciano de Investigación Biosanitaria (IMIB) Murcia Spain

4. European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN‐Guard Heart) Amsterdam The Netherlands

5. Departament of Internal Medicine (Cardiology) Universidad de Murcia Murcia Spain

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.14142

Reference63 articles.

1. Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults

2. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

3. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines;Ommen S;Circulation,2020

4. Hypertrophic Cardiomyopathy

5. Metabolic Modulator Perhexiline Corrects Energy Deficiency and Improves Exercise Capacity in Symptomatic Hypertrophic Cardiomyopathy

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and safety of mavacamten in healthy Chinese participants with different CYP2C19 phenotypes;Clinical and Translational Science;2024-07

2. Asymmetrical Septal Hypertrophy diagnosed by MRI: a case report;Proceedings of Scientific Research Universidad Anáhuac. Multidisciplinary Journal of Healthcare;2024-06-06

3. Hypertrophic cardiomyopathy and competitive sports: let ‘em play?;Current Opinion in Cardiology;2024-05-13

4. Concurrent Resistance and Cardiorespiratory Training in Patients with Hypertrophic Cardiomyopathy: A Pilot Study;Journal of Clinical Medicine;2024-04-17

5. 2024 Guidelines of the Taiwan Society of Cardiology for the Diagnosis and Treatment of Heart Failure with Preserved Ejection Fraction;ACTA CARDIOL SIN;2024